title: [Attention-deficit/hyperactivity disorder. Clinical and treatment aspects].
abstract: Attention-Deficit / Hyperactivity Disorder (ADHD) is a complex disorder. The onset of the disease is in childhood. The most important symptoms of ADHD are hyperactive, impulsive and inattention symptoms. In addition, children with this syndrome often have difficulties with other aspects of their learning, emotional modulation, organization, motivation, memory and other functions of the brain's management system. Drug medications, behavioral treatment and behavioral interventions at school are the most important aspects of treatment for ADHD syndrome.
authors.affiliation: Facultatea de Medicină, Clinica a III-a Pediatrie, Universitatea de Medicină si Farmacie "Gr. T. Popa" Iaşi.
authors.forename: Georgeta
authors.initials: G
authors.lastname: Diaconu
authors.forename: Ioana
authors.initials: I
authors.lastname: Grigore
authors.forename: M
authors.initials: M
authors.lastname: Burlea
mesh_terms: D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000661:Amphetamine / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy* / Q000523:psychology / Q000628:therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D007175:Impulsive Behavior / Q000209:etiology; D011582:Psychological Theory; D011595:Psychomotor Agitation / Q000209:etiology; D011788:Quality of Life; D013565:Sympatholytics / Q000627:therapeutic use
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants; D013565:Sympatholytics; D000661:Amphetamine